XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT

Realtime	Geld	Brief	Zeit
	1,230	1,290	17:52
	1,240	1,340	03.05.

Realtime

Geld

Brief

Zeit

1,230

1,290

17:52

1,240

1,340

03.05.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.08.2023

The following instruments on Boerse Frankfurt do have their last trading day on 17.08.2023
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.08.2023

ISIN Name
CA13509T1057 CANADA HOUSE CANNAB. GRP
CA7562302074 RECHARGE RESOURCES LTD.
LU1093307442 OSS.(L)-OSMAIGESC ETF1CEO
LU1128926646 HVB OPTI SEL.BALANCE R2
US00972G1085 AKARI THER.ADR/100 LS-,01
US03966V1070 ARCONIC CORP. DL-,01
US2537484048 DIFFUSION PHARMA. DL-,001
US42328V6039 HELIUS MEDICAL TECHNOLOG.

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!

In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.

Hier klicken

Zeit	Aktuelle Nachrichten
Mi	Akari Therapeutics Plc - 8-K, Current Report
Mi	Akari Therapeutics Appoints Samir Patel Interim CEO After CEO Rachelle Jacques Steps Down
Mi	Akari Therapeutics Plc: Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity	Prioritization of Peak's ADC cancer therapeutic platform technology and Akari's PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic diseaseAkari Therapeutics announces leadership changes in... ► Artikel lesen
Mi	Akari Therapeutics Plc: Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics	BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced... ► Artikel lesen
Mi	Peak Bio, Inc.: Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity	Prioritization of Peak's ADC cancer therapeutic platform technology and Akari's PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic diseaseAkari Therapeutics announces leadership changes... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Akari Therapeutics Plc - 8-K, Current Report

Akari Therapeutics Appoints Samir Patel Interim CEO After CEO Rachelle Jacques Steps Down

Akari Therapeutics Plc: Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity

Prioritization of Peak's ADC cancer therapeutic platform technology and Akari's PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic diseaseAkari Therapeutics announces leadership changes in...
► Artikel lesen

Akari Therapeutics Plc: Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics

BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced...
► Artikel lesen

Peak Bio, Inc.: Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity

Zeit	Aktuelle Nachrichten
23.04.	CervoMed Inc. - 8-K, Current Report
04.04.	CervoMed Inc. - 8-K, Current Report
01.04.	CervoMed GAAP EPS of -$0.82 beats by $1.23, revenue of $7.14M beats by $3.09M
01.04.	CervoMed Inc.: CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates	- Announced private placement of up to $149.4 million led by RA Capital Management with participation from Armistice Capital, Special Situations Funds and Soleus Capital; pro forma cash and cash equivalents... ► Artikel lesen
29.03.	CervoMed Inc reports results for the quarter ended in December - Earnings Summary

Zeit

Aktuelle Nachrichten

23.04.

CervoMed Inc. - 8-K, Current Report

04.04.

CervoMed Inc. - 8-K, Current Report

01.04.

CervoMed GAAP EPS of -$0.82 beats by $1.23, revenue of $7.14M beats by $3.09M

01.04.

CervoMed Inc.: CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates

- Announced private placement of up to $149.4 million led by RA Capital Management with participation from Armistice Capital, Special Situations Funds and Soleus Capital; pro forma cash and cash equivalents...
► Artikel lesen

29.03.

CervoMed Inc reports results for the quarter ended in December - Earnings Summary

Zeit	Aktuelle Nachrichten
Fr	Pre-market Movers: Helius Medical Technologies, AEON Biopharma, Sprout Social, El Pollo Loco, Terran Orbital	THOUSAND OAKS (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.05 A.M. ET).In the Green Helius Medical Technologies, Inc. (HSDT) is... ► Artikel lesen
Fr	CTMX, HSDT and SNSE are among premarket gainers
Fr	Why Is Helius Medical Technologies (HSDT) Stock Up 47% Today?
26.04.	HELIUS MEDICAL TECHNOLOGIES, INC. - S-1/A, General form for registration of securities
24.04.	Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

Zeit

Aktuelle Nachrichten

Pre-market Movers: Helius Medical Technologies, AEON Biopharma, Sprout Social, El Pollo Loco, Terran Orbital

THOUSAND OAKS (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.05 A.M. ET).In the Green Helius Medical Technologies, Inc. (HSDT) is...
► Artikel lesen

CTMX, HSDT and SNSE are among premarket gainers

Why Is Helius Medical Technologies (HSDT) Stock Up 47% Today?

26.04.

HELIUS MEDICAL TECHNOLOGIES, INC. - S-1/A, General form for registration of securities

24.04.

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

Zeit	Aktuelle Nachrichten
29.02.	MTL Cannabis Corp. Reports Third Quarter Results with $22.4 Million of Revenue and Continued Positive Operating Income and Cash Flows
12.12.23	MTL Cannabis Corp. Announces Extension of Indebtedness and Warrant Repricing
30.11.23	MTL Cannabis Corp: MTL Cannabis earns $1.99-million in Q2 2023
30.11.23	MTL Cannabis Corp. Reports Second Quarter Results with $23.1 Million of Revenue, $2.4 Million of Net Income, and $2.8M of Positive Cash Flows
01.11.23	XFRA J4E: WIEDERAUFNAHME/RESUMPTION	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen

Zeit

Aktuelle Nachrichten

29.02.

MTL Cannabis Corp. Reports Third Quarter Results with $22.4 Million of Revenue and Continued Positive Operating Income and Cash Flows

12.12.23

MTL Cannabis Corp. Announces Extension of Indebtedness and Warrant Repricing

30.11.23

MTL Cannabis Corp: MTL Cannabis earns $1.99-million in Q2 2023

30.11.23

MTL Cannabis Corp. Reports Second Quarter Results with $23.1 Million of Revenue, $2.4 Million of Net Income, and $2.8M of Positive Cash Flows

01.11.23

XFRA J4E: WIEDERAUFNAHME/RESUMPTION

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen

Zeit	Aktuelle Nachrichten
26.03.	Recharge Resources Ltd (3): Recharge enters advisory mandate with Eden for Pocitos
26.03.	Recharge Resources Ltd. sichert sich ein strategisches Beratungsmandat mit Eden Capital Markets zur Finanzierung des Projekts Pocitos	Vancouver, BC - 26. März 2024 / IRW-Press / - Recharge Resources Ltd. ("Recharge" oder das "Unternehmen") (RR: CSE) (RECHF: OTC) (SL50: Frankfurt) freut sich, den Abschluss eines Beratungsmandates... ► Artikel lesen
12.03.	Recharge Resources Ltd (3): Ranchero Gold closes Pinchi Lake option with Recharge
12.03.	Recharge Resources Ltd (3): Recharge Resources begins drill preparations at Pocitos
12.03.	Recharge Resources beginnt mit den Bohrvorbereitungen zur Aufwertung und Erweiterung der Mineralressourcenschätzung von 760.000 Tonnen Lithiumcarbonat-Äquivalent im Lithium-Sole-Projekt Pocitos	Vancouver, BC - 12. März 2024 / IRW-Press / - Recharge Resources Ltd. ("Recharge" oder das "Unternehmen") (RR: CSE) (RECHF: OTC) (SL5: Frankfurt) freut sich, den Besuch von Jason Van Den Akker... ► Artikel lesen

Zeit

Aktuelle Nachrichten

26.03.

Recharge Resources Ltd (3): Recharge enters advisory mandate with Eden for Pocitos

26.03.

Recharge Resources Ltd. sichert sich ein strategisches Beratungsmandat mit Eden Capital Markets zur Finanzierung des Projekts Pocitos

Vancouver, BC - 26. März 2024 / IRW-Press / - Recharge Resources Ltd. ("Recharge" oder das "Unternehmen") (RR: CSE) (RECHF: OTC) (SL50: Frankfurt) freut sich, den Abschluss eines Beratungsmandates...
► Artikel lesen

12.03.

Recharge Resources Ltd (3): Ranchero Gold closes Pinchi Lake option with Recharge

12.03.

Recharge Resources Ltd (3): Recharge Resources begins drill preparations at Pocitos

12.03.

Recharge Resources beginnt mit den Bohrvorbereitungen zur Aufwertung und Erweiterung der Mineralressourcenschätzung von 760.000 Tonnen Lithiumcarbonat-Äquivalent im Lithium-Sole-Projekt Pocitos

Vancouver, BC - 12. März 2024 / IRW-Press / - Recharge Resources Ltd. ("Recharge" oder das "Unternehmen") (RR: CSE) (RECHF: OTC) (SL5: Frankfurt) freut sich, den Besuch von Jason Van Den Akker...
► Artikel lesen

Unternehmen / Aktien	Kurs	%
AKARI THERAPEUTICS PLC ADR	1,300	-13,91 %
CERVOMED INC	24,125	-0,06 %
HELIUS MEDICAL TECHNOLOGIES INC	2,480	-31,11 %
MTL CANNABIS CORP	0,236	0,00 %
RECHARGE RESOURCES LTD	0,086	+0,94 %

Unternehmen / Aktien

Kurs

AKARI THERAPEUTICS PLC ADR

1,300

-13,91 %

CERVOMED INC

24,125

-0,06 %

HELIUS MEDICAL TECHNOLOGIES INC

2,480

-31,11 %

MTL CANNABIS CORP